279 related articles for article (PubMed ID: 19948031)
1. Aberrant trafficking of NSCLC-associated EGFR mutants through the endocytic recycling pathway promotes interaction with Src.
Chung BM; Raja SM; Clubb RJ; Tu C; George M; Band V; Band H
BMC Cell Biol; 2009 Nov; 10():84. PubMed ID: 19948031
[TBL] [Abstract][Full Text] [Related]
2. Nexus of signaling and endocytosis in oncogenesis driven by non-small cell lung cancer-associated epidermal growth factor receptor mutants.
Chung BM; Tom E; Zutshi N; Bielecki TA; Band V; Band H
World J Clin Oncol; 2014 Dec; 5(5):806-23. PubMed ID: 25493220
[TBL] [Abstract][Full Text] [Related]
3. The role of cooperativity with Src in oncogenic transformation mediated by non-small cell lung cancer-associated EGF receptor mutants.
Chung BM; Dimri M; George M; Reddi AL; Chen G; Band V; Band H
Oncogene; 2009 Apr; 28(16):1821-32. PubMed ID: 19305428
[TBL] [Abstract][Full Text] [Related]
4. Differential parsing of EGFR endocytic flux among parallel internalization pathways in lung cancer cells with EGFR-activating mutations.
Walsh AM; Lazzara MJ
Integr Biol (Camb); 2014 Mar; 6(3):312-23. PubMed ID: 24445374
[TBL] [Abstract][Full Text] [Related]
5. The EGFR inhibitor gefitinib suppresses ligand-stimulated endocytosis of EGFR via the early/late endocytic pathway in non-small cell lung cancer cell lines.
Nishimura Y; Bereczky B; Ono M
Histochem Cell Biol; 2007 May; 127(5):541-53. PubMed ID: 17361439
[TBL] [Abstract][Full Text] [Related]
6. USP17 is required for trafficking and oncogenic signaling of mutant EGFR in NSCLC cells.
McCann AP; Smyth P; Cogo F; McDaid WJ; Jiang L; Lin J; Evergren E; Burden RE; Van Schaeybroeck S; Scott CJ; Burrows JF
Cell Commun Signal; 2018 Nov; 16(1):77. PubMed ID: 30409180
[TBL] [Abstract][Full Text] [Related]
7. Evidence for efficient phosphorylation of EGFR and rapid endocytosis of phosphorylated EGFR via the early/late endocytic pathway in a gefitinib-sensitive non-small cell lung cancer cell line.
Nishimura Y; Yoshioka K; Bereczky B; Itoh K
Mol Cancer; 2008 May; 7():42. PubMed ID: 18492291
[TBL] [Abstract][Full Text] [Related]
8. YC-1 potentiates the antitumor activity of gefitinib by inhibiting HIF-1α and promoting the endocytic trafficking and degradation of EGFR in gefitinib-resistant non-small-cell lung cancer cells.
Hu H; Miao XK; Li JY; Zhang XW; Xu JJ; Zhang JY; Zhou TX; Hu MN; Yang WL; Mou LY
Eur J Pharmacol; 2020 May; 874():172961. PubMed ID: 32044322
[TBL] [Abstract][Full Text] [Related]
9. EGF‑stimulated AKT activation is mediated by EGFR recycling via an early endocytic pathway in a gefitinib‑resistant human lung cancer cell line.
Nishimura Y; Takiguchi S; Ito S; Itoh K
Int J Oncol; 2015 Apr; 46(4):1721-9. PubMed ID: 25653196
[TBL] [Abstract][Full Text] [Related]
10. EGFR over-expression in non-small cell lung cancers harboring EGFR mutations is associated with marked down-regulation of CD82.
Yang CH; Chou HC; Fu YN; Yeh CL; Cheng HW; Chang IC; Liu KJ; Chang GC; Tsai TF; Tsai SF; Liu HP; Wu YC; Chen YT; Huang SF; Chen YR
Biochim Biophys Acta; 2015 Jul; 1852(7):1540-9. PubMed ID: 25912735
[TBL] [Abstract][Full Text] [Related]
11. The TWEAK Receptor Fn14 Is an Src-Inducible Protein and a Positive Regulator of Src-Driven Cell Invasion.
Cheng E; Whitsett TG; Tran NL; Winkles JA
Mol Cancer Res; 2015 Mar; 13(3):575-83. PubMed ID: 25392346
[TBL] [Abstract][Full Text] [Related]
12. FCHSD2 controls oncogenic ERK1/2 signaling outcome by regulating endocytic trafficking.
Xiao GY; Schmid SL
PLoS Biol; 2020 Jul; 18(7):e3000778. PubMed ID: 32678845
[TBL] [Abstract][Full Text] [Related]
13. PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells.
Bazzani L; Donnini S; Finetti F; Christofori G; Ziche M
Oncotarget; 2017 May; 8(19):31270-31287. PubMed ID: 28415726
[TBL] [Abstract][Full Text] [Related]
14. Lyn, a Src family kinase, regulates activation of epidermal growth factor receptors in lung adenocarcinoma cells.
Sutton P; Borgia JA; Bonomi P; Plate JM
Mol Cancer; 2013 Jul; 12():76. PubMed ID: 23866081
[TBL] [Abstract][Full Text] [Related]
15. Cell surface epidermal growth factor receptors increase Src and c-Cbl activity and receptor ubiquitylation.
Parks EE; Ceresa BP
J Biol Chem; 2014 Sep; 289(37):25537-45. PubMed ID: 25074934
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Src trafficking and activation by the endocytic regulatory proteins MICAL-L1 and EHD1.
Reinecke JB; Katafiasz D; Naslavsky N; Caplan S
J Cell Sci; 2014 Apr; 127(Pt 8):1684-98. PubMed ID: 24481818
[TBL] [Abstract][Full Text] [Related]
17. The exon 19-deleted EGFR undergoes ubiquitylation-mediated endocytic degradation via dynamin activity-dependent and -independent mechanisms.
Wang T; Zhang J; Wang S; Sun X; Wang D; Gao Y; Zhang Y; Xu L; Wu Y; Wu Y; Liu F; Liu X; Liu S; Zhang Y; Wang Y; Zou L; Liu H
Cell Commun Signal; 2018 Jul; 16(1):40. PubMed ID: 29976202
[TBL] [Abstract][Full Text] [Related]
18. Protein tyrosine phosphatase PTPN3 inhibits lung cancer cell proliferation and migration by promoting EGFR endocytic degradation.
Li MY; Lai PL; Chou YT; Chi AP; Mi YZ; Khoo KH; Chang GD; Wu CW; Meng TC; Chen GC
Oncogene; 2015 Jul; 34(29):3791-803. PubMed ID: 25263444
[TBL] [Abstract][Full Text] [Related]
19. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
20. miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer.
Baumgartner U; Berger F; Hashemi Gheinani A; Burgener SS; Monastyrskaya K; Vassella E
Mol Cancer; 2018 Feb; 17(1):44. PubMed ID: 29455644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
